Merck Millipore introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials. The newest enhancements enable the selection of raw and starting materials based on their risk assessment: Essential products for moderate risk level applications; Expert products for higher risk applications where low microbiological and endotoxin levels are critical; API products, GMP compliant and provided of the quality and regulatory documentation required for approval.


Please enter your comment!
Please enter your name here